NCT06855368 · RECRUITING
Biomarkers for Monitoring Dementia Progression
This study is measuring brain connectivity and other biological markers in people with mild Alzheimer's disease or mild cognitive impairment (MCI), comparing them to healthy adults. Researchers also plan to test anti-inflammatory nanoparticles in a mouse model. There is no phase listed, which typically means this is observational or early-stage research, not a treatment trial for humans yet. Details on study size and location are limited.
You may qualify if
- mild AD and patients with mild cognitive impairment (MCI).
You're excluded if
- major psychosis, genetic, metabolic and other neurological disorders, acute or chronic non-compensated medical illness
- any medical or drug-related condition affecting cognitive or mood status
- history or current alcohol/illicit drug abuse.
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2025-03-03